Back to News
Market Impact: 0.1
Parabilis Medicines Names Former J&J Oncology Executive Craig Tendler To Board
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Parabilis Medicines (PBLS) appointed Craig L. Tendler, M.D. to its Board of Directors, continuing his role as a scientific advisor. The update is governance/oversight-focused and does not cite any new clinical, financial, or regulatory milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
PBLS0.20
More News
- Bank of America is bullish on these top stocks ahead of earnings
- Big Tech is betting $700 billion on AI. Healthcare will decide whether the bet pays off
- ‘I drive a Tesla’: After Elon Musk said he’d lose his job, Delta CEO Ed Bastian says there’s ‘no tit for tat’ as airline unveils earnings miss
- Teva wins FDA approval for monthly schizophrenia injection Weltruza
- BofA downgrades Alignment Healthcare stock rating on star rating drop
- Trump created a committee to dig into the Fed's Lisa Cook. What is it and what comes next?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Capital IQ Alternatives for Research and Deal Work
- Research Workflows, Report Format Selection, and Interactive Synthesis